Navigation Links
Nuevolution Announces Drug Discovery Alliance With Lexicon Pharmaceuticals
Date:6/10/2008

drug screening at an unprecedented scale," said Alex Gouliaev, CEO of Nuevolution A/S. "We believe this generates high quality hits and leads far more rapidly and reliably than current ultra high throughput methods. Combining our platform with Lexicon's highly validated target portfolio represents an exceptional drug discovery opportunity and we very much look forward to bringing together Lexicon's expertise in biology and ours in chemistry, creating a synergistic biotech alliance."

"This important alliance is designed to accelerate Lexicon's ability to move from novel knockout validated targets to drug candidates as we continue to build our pipeline of innovative products," said Brian Zambrowicz, Ph.D., executive vice president and chief scientific officer of Lexicon.

About Nuevolution

Nuevolution is a leading drug discovery company founded in 2001 and based in Copenhagen, Denmark. The company has developed Chemetics(R), a unique, patent protected hybrid of proven wet chemistry and molecular biology which represents the ultimate fragment based drug discovery technology. Chemetics(R) enables rapid synthesis and DNA-tagging of hundreds of millions of chemically diverse drug-like small molecule compounds and the efficient screening of these, facilitating the identification of potent drug leads at unprecedented quantity, quality and speed compared to existing drug discovery technologies.

Nuevolution partners its technology with pharmaceutical and biotechnology companies, and is also developing an internal pipeline by applying Chemetics(R) to validated cancer and cardiovascular targets. Nuevolution has demonstrated the power of Chemetics(R) by identifying highly potent and drug like novel ligands with the potential to address major unmet medical needs across a range of therapeutic areas and target classes.

Nuevolution is a privately owned company and has raised EUR 37 million in financing from key Scandinavian investors, including SEB
'/>"/>

SOURCE Nuevolution A/S
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. onTargetjobs Announces Appointment of Michael Tansey as New CEO
2. Tethys Bioscience Announces Expanded Availability of PreDx(TM) Diabetes Risk Test
3. QLT announces positive Health Canada decision on Aczone(R)
4. ETHICON, INC. Announces Revised Label For REGRANEX(R) (becaplermin) Gel 0.01%
5. Telik Announces Presentation and Webcast at Needham Biotechnology Conference
6. Biopure Announces MHRA Meeting Update
7. BioMarin Announces Program for ERT for Treatment of MPS IVA - Morquio A Syndrome
8. Millennium Biotechnologies Announces an Increased Annualized Purchase Commitment Totaling $5.8M from Provider Services, Inc.
9. American Oriental Bioengineering Announces that it Withdraws Convertible Preferred Stock Offering
10. Exelixis Announces June 5 Webcast of Conference Call Regarding Its $150 Million Funding Commitment from Deerfield Management
11. Synthetech Announces Fiscal 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... a new microscopy technology that allows them to ... resolution. , Dubbed "Complementation Activated Light Microscopy" (CALM), ... an order of magnitude finer than conventional optical ... biomolecules at the nanometer scale. , In a ... Communications , the researchers behind CALM used it ...
(Date:9/18/2014)... Silicon-valley Electronic Data Capture (EDC) provider ... the latest addition to Clinovo’s CRO Partnership Program. With ... Program, Clinovo further expands its global reach to Latin ... we are now able to build studies on our ... also rely on Clinovo to fully support the solution ...
(Date:9/18/2014)... Whitehouse Laboratories is pleased to announce that ... has acquired an additional 4,000 square feet of dedicated ... adjacent to its current package testing facility. The official ... Whitehouse Labs is in the process of upgrading the ... testing. The prime location enables Whitehouse Labs to immediately ...
(Date:9/17/2014)... LONDON , Sept. 17, 2014 The global ... Tons by 2019. Squalene is a natural skin-identical chemical that ... & personal care, food supplements, pharmaceuticals, and in other applications ... The squalene market has a few major players and is ... (U.S.), Kishimoto Special Liver Oil Co. Ltd. ( Japan ...
Breaking Biology Technology:Scientists pioneer microscopy technique that yields fresh data on muscular dystrophy 2Digitaliza TXT Joins Clinovo’s CRO Partnership Program, Bringing Its Open Source EDC System, ClinCapture to Latin America 2Digitaliza TXT Joins Clinovo’s CRO Partnership Program, Bringing Its Open Source EDC System, ClinCapture to Latin America 3Whitehouse Labs Announces Package Testing Laboratory Expansion 2Whitehouse Labs Announces Package Testing Laboratory Expansion 3Whitehouse Labs Announces Package Testing Laboratory Expansion 4Squalene Market by Source (Animal & Vegetable) & by End-user Industry (Cosmetics, Pharmaceuticals & Food Industry) - Global Trends & Forecasts to 2019 2Squalene Market by Source (Animal & Vegetable) & by End-user Industry (Cosmetics, Pharmaceuticals & Food Industry) - Global Trends & Forecasts to 2019 3
... an effort to spur entrepreneurship in a broader range ... has named the University of Wisconsin-Madison as ... has received $5 million to help train students in ... in 2004 to bring entrepreneurship education to a wider ...
... to provide end-to-end approach to retail workforce optimization ... and the Denver-based StorePerform Technologies, Inc. , ,The ... in the next 20 to 30 days. Financial terms were ... part of RedPrairie's retail productivity division, previously known as ...
... this is my last article of the year, and I have ... my New Year's resolution for this column is bring back more ... is that I simply have not gone to as many concerts ... will need to remedy!) , ,Looking over 2006, my focus has ...
Cached Biology Technology:UW gets $5M to extend entrepreneurship 22006: A great biotech financing year, unless you were going public! 22006: A great biotech financing year, unless you were going public! 32006: A great biotech financing year, unless you were going public! 42006: A great biotech financing year, unless you were going public! 5
(Date:9/17/2014)... EC-FP5 four-year project, delivering its first release in 2004. ... in several EC projects, as a part of the ... BON), to increase the general awareness of the work ... dissemination of the Fauna Europaea results, the ... e-Publishing tools to prepare data papers for all 56 ...
(Date:9/17/2014)... Copenhagen Centre for Social Evolution and Yale University offers ... weight and -length can partially predict the likelihood of ... and schizophrenia later in life. The study analyzed medical ... diagnoses for up to 30 years, and adjusted for ... published today in the Proceedings of the Royal ...
(Date:9/17/2014)... EAST LANSING, Mich. Mutations in the human retinoblastoma ... Now, Michigan State University scientists have turned to fruit ... cancer gene. , In a paper featured on ... Journal of Biological Chemistry , Michigan State University researchers ... mutations similar to those present in the human cancer ...
Breaking Biology News(10 mins):Contributions on Fauna Europaea: Data papers as innovative model on expert involvement 2Size at birth affects risk of adolescent mental health disorders 2Size at birth affects risk of adolescent mental health disorders 3Abnormal properties of cancer protein revealed in fly eyes 2
... , This news release is available in ... diseases like Parkinson,s disease involve the death of thousands of neurons ... as GDNF, promote the survival of the neurons; however, clinical tests ... the Max Planck Institute of Neurobiology in Martinsried and their colleagues ...
... year around 11 million people suffer severe burns. The resulting ... results in lifelong scars. What is needed to reduce this ... Only a very limited area of skin can be removed ... new wounds. Besides conventional skin grafting, another option is to ...
... synthetic biology will be established in Bristol, Nottingham ... from the Biotechnology and Biological Sciences Research Council ... Council (EPSRC). The 40M+ investment will be ... David Willetts tonight at a BBSRC event in ...
Cached Biology News:Parkinson gene: Nerve growth factor halts mitochondrial degeneration 2Parkinson gene: Nerve growth factor halts mitochondrial degeneration 3Blood and lymphatic capillaries grown for the first time in the lab 2UK establishes 3 new synthetic biology research centers 2
Purified Mouse anti-Hu LAT (pY226) Storage Temperature: Refrigerate(2 to 8C)...
Component in MasterPure™ Purification Kits...
Human Cell Line Slides...
Chicken polyclonal to YebU ( Abpromise for all tested applications). Antigen: Full length YebU (Escherichia coli)...
Biology Products: